XML 25 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Cash flows from operating activities    
Net income $ 12,087 $ 4,795
Adjustments to reconcile net income to net cash used in operating activities:    
Gain on sale of assets (285) (8)
Depreciation and amortization 7,684 7,487
Impairment loss on assets   1,024
Deferred income taxes 1,651 2,093
Noncash compensation related to stock plans 2,657 2,977
Excess tax benefit of options exercised (8)  
Provision for doubtful accounts (53) (39)
Changes in operating assets and liabilities, net of acquisitions:    
Trade accounts receivable (24,220) (21,006)
Inventories (19,128) 823
Trade accounts payable (3,403) (5,578)
Income taxes payable 4,140 927
Accrued profit sharing trust contributions (3,770) (3,335)
Accrued cash profit sharing and commissions 2,057 1,318
Other current assets (2,977) 16
Accrued liabilities (5,022) (9,179)
Long-term liabilities (950) (612)
Accrued workers' compensation 528 (18)
Other noncurrent assets 54 (417)
Net cash used in operating activities (28,958) (18,732)
Cash flows from investing activities    
Capital expenditures (4,193) (4,632)
Asset acquisitions, net of cash acquired   (5,300)
Proceeds from sale of property and equipment 451 17
Loan repayment by related parties   605
Net cash used in investing activities (3,742) (9,310)
Cash flows from financing activities    
Deferred and contingent consideration paid for asset acquisition (1,294)  
Debt and line of credit borrowings   1,080
Repayment of debt and line of credit borrowings (20) (20)
Issuance of common stock 1,769 496
Excess tax benefit of options exercised 8  
Dividends paid (6,089) (6,053)
Net cash used in financing activities (5,626) (4,497)
Effect of exchange rate changes on cash and cash equivalents (894) (1,049)
Net decrease in cash and cash equivalents (39,220) (33,588)
Cash and cash equivalents at beginning of period 251,208 175,553
Cash and cash equivalents at end of period 211,988 141,965
Noncash activity during the period    
Noncash capital expenditures 406 140
Dividends declared but not paid 6,116  
Issuance of Company's common stock for compensation $ 402 $ 315